Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

F, Carrat; H, Fontaine; C, Dorival; M, Simony; A, Diallo; C, Hezode; Ledinghen V, De; D, Larrey; G, Haour; JP, Bronowicki; F, Zoulim; T, Asselah; P, Marcellin; D, Thabut; V, Leroy; A, Tran; F, Habersetzer; D, Samuel; D, Guyader; O, Chazouilleres; P, Mathurin; S, Metivier; L, Alric; G, Riachi; J, Gournay; A, Abergel; P, Cales; N, Ganne; V, Loustaud-Ratti; L, D'Alteroche; X, Causse; C, Geist; A, Minello; I, Rosa; M, Gelu-Simeon; I, Portal; F, Raffi; M, Bourliere; S, Pol

doi:10.1016/s0140-6736(18)32111-1

Public

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

Shared by NobleBlocks on Feb 11, 2019 • 12:00 AM UTC

Authors:

Carrat F

Fontaine H

Dorival C

Abstract

Background Although direct-acting antivirals have been used extensively to treat patients with chronic hepatitis C virus (HCV) infection, their clinical effectiveness has not been well reported. We compared the incidence of death, hepatocellular carcinoma, and decompensated cirrhosis between patient...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!